Loading viewer...
earnings
Format: PDF earnings
Ambu presents Q4 2013/14 financial results and FY 2014/15 guidance, highlighting 11% organic growth and strong performance in key product lines including aScope 3 and laryngeal masks. The company reports 36% EBIT increase with an EBIT margin of 18.1% and improving gross margins as planned.
investor_presentation
13 Pages
earnings
34 Pages
Worldline